Thomas Zeltner

Last updated
Thomas Zeltner
Born (1947-11-15) November 15, 1947 (age 72)
OccupationChairman WHO Foundation, physician, lawyer, and former Secretary of Health of Switzerland
Known forFormer Secretary of Health of Switzerland; co-founder of the Global Patient Safety Forum; Professor of Public Health at the University of Berne, Switzerland; Visiting Scientist at the Harvard School of Public Health; President of the Swiss Commission for UNESCO; and Board Member of the Medical University of Vienna

Thomas Zeltner (born 1947 in Berne, Switzerland) is a Swiss physician, lawyer, and former Secretary of Health of Switzerland Federal Department of Home Affairs FDHA. He has a long history in public health and has repeatedly been ranked among the 12 most influential political figures of Switzerland. [1]


Zeltner is Professor at the University of Berne, Switzerland, in Public Health and Visiting Scientist at the Harvard School of Public Health. He chairs the Swiss Research Institute for Public Health and Addiction (Zürich) and is President of UNESCO Commission of Switzerland. He advises the Swiss government in the implementation and future development of The National Health Policy. He is also the Vice Chair of the University Council of the Medical University of Vienna.

He is the first chairman of the WHO Foundation established in Geneva.

Along with J. Michael Henderson, he is a co-founder of the Global Patient Safety Forum, a collaborative forum for global healthcare leaders. He is President of KPT Health Insurance, Switzerland and of Swiss Transfusion SRC Inc.


Zeltner was graduated with an M.D. and an LL.M. (master's in law) from the University of Berne. He specialized in human pathology and forensic medicine before becoming the head of Medical Services at the Bern University Hospital. He held various faculty positions at the University of Bern and at the Harvard School of Public Health. He is Doctor of law (honoris causa) of the University of Neuchâtel, Switzerland.

In 1991, the Swiss Government appointed Zeltner as the 8th Director-General of the Swiss National Health Authority and Secretary of Health of Switzerland, a position he held until the end of 2009.

Under Zeltner's leadership, Switzerland developed in 1991 a pioneering illicit drug policy, which has received global attention. It is based on a 4-pillar strategy (prevention, harm reduction, therapy, and law enforcement), which is enshrined in the Swiss law on narcotic drugs. The harm reduction policy of Switzerland – which includes large-scale syringe exchange programs (also in prisons) [2] and the medical prescription of heroin for chronic heroin addicts – was introduced against the strong opposition of the UN drug control authorities, [3] but endorsed by a majority of the Swiss population in several popular referenda. [4]

In 1999-2000, at the request of the then-Director General of WHO, Gro Harlem Brundtland, Zeltner chaired a committee which investigated the efforts of multinational tobacco companies to undermine tobacco control activities of the World Health Organization (2000). [5] This landmark report marks the beginning of the development of the WHO Framework Convention on Tobacco Control (2003). [6] With his efforts to reduce tobacco consumption in Switzerland, Zeltner became a favorite adversary of big tobacco and was nicknamed “the Tobacco Taliban." [7]

As Director General of the Swiss Federal Office of Public Health, he presided over changes to transform the regulated market model of the Swiss health care sector into a more value- and consumer-driven health care system. The Swiss model guarantees access to affordable insurance to all, even if they have pre-existing medical problems. All residents are required to buy insurance even if they are currently healthy, so that the risk pool remains reasonably favorable. Finally subsidies are given to low income families to pay for their premiums. Even though the Swiss pay 12.18% of the GDP for health (data 2018), [8] a majority of 78% considers that the system works well or very well. [9] The Swiss health care model is gaining increased international interest, particularly in the U.S. [10]

Zeltner was a member and Vice-President of the Executive Board of the World Health Organization (WHO) (1999-2002). He chaired the committee to reform the governance rules of the WHO in 2002-4. He was also Executive President of the WHO Regional Committee for Europe (1994–95) and Chairman of the Governing Council of the International Agency for Research on Cancer, (1998-2000). Between 2012 and 2014, Zeltner served the World Health Organization (WHO) in the capacity of a Special Envoy. [11] In this function he advised the Director General of WHO, Margaret Chan, in critical areas of the ongoing reform of this UN agency [12] [13] . The work was successfully completed by adoption of the Framework of Engagement with Non-State Actors (FENSA) by the World Health Assembly in May 2016.

Current position

He is co-founder of the Global Patient Safety Forum, a convening organization of world patient safety organizations; and a member of the steering board of the Global Patient Safety Challenge, Medication Safety, of the World Health Organization. He is a member of the editorial board of the journal Health Systems and Reform.

Since 1992, he has been Professor of Public Health at the University of Berne and is a Visiting Scientist at the Harvard School of Public Health (Boston). From 2018-22 he serves as a member of the Board of the Medical University of Vienna (Austria). Zeltner has served as Chairman of the board of the health insurer KPT, the leading online insurance company in Switzerland, which is repeatedly qualified as the best health insurer of Switzerland. [14] He is also president of Blood Transfusion CRS Switzerland, the organization in charge of securing Switzerland's provision with blood and blood products.

In 2020, the World Health Organization (WHO) announced [15] that Zeltner was one of the founding board members of (and the first chairman of) the WHO Foundation. The Foundation which is legally separate from WHO, will simplify the processing of philanthropic contributions in support of WHO.

Related Research Articles

A health system, also sometimes referred to as health care system or as healthcare system, is the organization of people, institutions, and resources that deliver health care services to meet the health needs of target populations.

Harm reduction range of public health policies designed to lessen the negative social and/or physical consequences associated with various human behaviors, both legal and illegal

Harm reduction, or harm minimization, refers to a range of public health policies designed to lessen the negative social and/or physical consequences associated with various human behaviors, both legal and illegal. Harm reduction policies are used to manage behaviors such as recreational drug use and sexual activity in numerous settings that range from services through to geographical regions.

American Medical Association U.S. association of physicians and medical students

The American Medical Association (AMA), founded in 1847 and incorporated in 1897, is the largest association of physicians—both MDs and DOs—and medical students in the United States.

Students for Sensible Drug Policy International civic engagement and advocacy organization

Students for Sensible Drug Policy (SSDP) is an international non-profit advocacy and education organization based in Washington D.C. SSDP is focused on reforming drug policy in the United States and internationally. SSDP is the only international network of students dedicated to ending the war on drugs. At its heart, SSDP is a grassroots organization, led by a student-run Board of Directors. SSDP creates change by bringing young people together and creating safe spaces for students of all political and ideological stripes to have honest conversations about drugs and drug policy. Founded in 1998, SSDP comprises thousands of members at hundreds of campuses in countries around the globe.

Abdol Hamid Ghodse was an academic in the field of substance abuse and addiction.

Julio Frenk Mexican politician

Julio José Frenk Mora is a Mexican physician and former secretary of Health of Mexico. Frenk is currently the president of the University of Miami. He is the University of Miami's first Hispanic and native Spanish-speaking president. Frenk formerly served as dean of the faculty and T & G Angelopoulos professor of public health and international development at the Harvard School of Public Health, from 2009 to 2015, where he had been the university's first Hispanic and native Spanish-speaking dean.

Drug policy reform, also known as drug law reform, is any proposed changes to the way governments respond to the socio-cultural influence on perception of psychoactive substance use. Proponents of drug policy reform believe that prohibition of drugs—such as cannabis, opioids, cocaine, amphetamines and hallucinogens—has been ineffectual and counterproductive. They argue that, rather than using laws and enforcement as the primary means to responding to substance use, governments and citizens would be better served by reducing harm and regulating the production, marketing, and distribution of currently illegal drugs in a manner similar to how alcohol and tobacco are regulated.

Action on Smoking and Health (ASH) is the name of a number of autonomous pressure groups (charities) that seek to publicize the risks associated with tobacco smoking and campaign for greater restrictions on cigarette and tobacco sales.

A public hospital, or government hospital, is a hospital which is government owned and is fully funded by government and operates solely off the money that is collected from taxpayers to fund healthcare initiatives. In some countries, this type of hospital provides medical care free of charge to patients, covering expenses and wages by government reimbursement.

Health policy Policy area, which deals with the planning, organization, management and financing of the health system

Health policy can be defined as the "decisions, plans, and actions that are undertaken to achieve specific healthcare goals within a society". According to the World Health Organization, an explicit health policy can achieve several things: it defines a vision for the future; it outlines priorities and the expected roles of different groups; and it builds consensus and informs people.

Tobacco harm reduction (THR) is a public health strategy to lower the health risks to individuals and wider society associated with using tobacco products. It is an example of the concept of harm reduction, a strategy for dealing with the abuse of other drugs. Tobacco smoking is widely acknowledged as a leading cause of illness and death, and reducing smoking is vital to public health.

Illicit drug use in Australia is the recreational use of prohibited drugs in Australia. Illicit drugs include illegal drugs, pharmaceutical drugs when used for non-medical purposes, and other substances used inappropriately. According to government and community organisations, the use and abuse, and the illegality, of illicit drugs is a social, health and legal issue that creates an annual illegal market estimated to be worth A$6.7 billion.

Health in Bhutan is one of the government's highest priorities in its scheme of development and modernization. Health and related issues are overseen by the Ministry of Health, itself represented on the executive Lhengye Zhungtshog (cabinet) by the Minister of Health. As a component of Gross National Happiness, affordable and accessible health care is central to the public policy of Bhutan.

The Ministry of National Health Services, Regulation and Coordination is a cabinet level ministry of the Government of Pakistan with responsibility for national public health.

The Vienna Declaration (2010) was a call for evidence-based drug policies prompted by the failure of traditional drug policies in the HIV/AIDS pandemic.

K. Srinath Reddy Indian cardiologist

K. Srinath Reddy is the president of the Public Health Foundation of India and formerly headed the Department of Cardiology at All India Institute of Medical Sciences (AIIMS).

The R Street Institute is an American conservative and libertarian think tank headquartered in Washington, D.C. The Institute's stated mission is to "engage in policy research and outreach to promote free markets and limited, effective government." R Street was established in 2012 when its founders split from the Heartland Institute out of disagreement with Heartland's public denial of the scientific consensus on climate change. In addition to its Washington headquarters, R Street has branch offices in Tallahassee, Florida; Columbus, Ohio; Sacramento, CA; Boston, MA; and Round Rock, TX.

Ann McNeill British academic/tobacco policy expert

Professor Ann McNeill is a British academic and tobacco policy expert. She is currently a Professor of Tobacco Addiction in the National Addictions Centre at the King's College London Institute of Psychiatry and Deputy Director of the UK Centre for Tobacco Control Studies.

The scientific community in United States and Europe are primarily concerned with the possible effect of electronic cigarette use on public health. There is concern among public health experts that e-cigarettes could renormalize smoking, weaken measures to control tobacco, and serve as a gateway for smoking among youth. The public health community is divided over whether to support e-cigarettes, because their safety and efficacy for quitting smoking is unclear. Many in the public health community acknowledge the potential for their quitting smoking and decreasing harm benefits, but there remains a concern over their long-term safety and potential for a new era of users to get addicted to nicotine and then tobacco. There is concern among tobacco control academics and advocates that prevalent universal vaping "will bring its own distinct but as yet unknown health risks in the same way tobacco smoking did, as a result of chronic exposure", among other things.

Gerry Stimson is a British public health social scientist, emeritus professor at Imperial College London from 2014, and an honorary professor at the London School of Hygiene and Tropical Medicine from 2017. Stimson has over 220 scientific publications mainly on social and health aspects of illicit drug use, including HIV infection. He has sat on numerous editorial boards including AIDS, Addiction, and European Addiction Research, and with Tim Rhodes he was the co-editor-in-chief of the International Journal of Drug Policy from 2000 to 2016. He is one of the global leaders for research on and later advocacy for harm reduction.


  1. Die Mächtigsten: Geballte Macht
  2. "Nicole Pepper for the Harm Reduction Coalition. Syringe Exchange in Prisons: The International Experience". Harm Reduction Coalition. 2007. Retrieved 31 Jul 2013.
  3. "Report of the International Narcotics Control Board for 1995" (PDF). International Narcotics Control Board. 1996. Retrieved 31 Jul 2013.
  4. Savary JF, Hallam C, Bewley-Taylor D (2009). "The Swiss Four Pillars Policy: an evolution from local experimentation to federal law" (PDF). The Beckley Foundation Drug Policy Programme. Briefing Paper Eighteen.
  5. Zeltner T, Kessler DA, Martiny A, Randera F (Jul 2000). "Tobacco Company Strategies to Undermine Tobacco Control Activities at the World Health Organization. Report of the Committee of Experts on Tobacco Industry Documents" (PDF). Geneva, Switzerland. Retrieved 2 August 2013.
  6. Reynolds LA, Tansey EM, eds. (2010) The transcript of a Witness Seminar organized by the Wellcome Trust Centre for the History of Medicine at UCL, in collaboration with the Department of Knowledge Management and Sharing, WHO, held in Geneva, on 26 February 2010. WHO Framework Convention on Tobacco Control. Retrieved 31 Jul 2013.
  7. Ullekh NP (Jun 2, 2013). "Tobacco industry's bet on India & China may lead to surge in lifestyle diseases: Thomas Zeltner". The Economic Times (India).
  8. "Swiss Federal Statistical Office: Costs, financing". Swiss Federal Administration. 2013. Retrieved 1 August 2013.
  9. "Trend zu mehr Eigenverantwortung und weniger Solidarität". Interpharma. 2013. Retrieved 1 August 2013.
  10. Cheng T-M (2010). "Understanding the 'Swiss watch' function of Switzerland's health system". Health Aff (Millwood). 29 (8): 1442–51. doi: 10.1377/hlthaff.2010.0698 . PMID   20707011.
  11. Cassels A. (Apr 2013). "Change @ WHO: New approach to financing". World Health Organization. Retrieved 1 August 2013.
  12. "WHO needs change". Nature Publishing Group. 12 May 2011. Retrieved 30 July 2013.
  13. "WHO reform process: Landmark events of the WHO reform process from the initial consultation on the future of financing for WHO". World Health Organization. Retrieved 30 July 2013.
  14. "Die KPT ist erneut Spitze im Service" (in German). Konsumenteninfo AG. 19 Sep 2012. Retrieved 1 August 2013.
  15. "WHO Foundation Established to Support Critical Global Health Needs". World Health Organization (see also: "WHO dot int", and "whofoundationproject dot org" ). May 27, 2020. Archived from the original on May 27, 2020. Retrieved May 27, 2020. Founding Board Members are: Mr. Bob Carter, Ms. Clare Akamanzi and Professor Thomas Zeltner.